Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant: Priority Announcement (IHSPR)

University of Calgary

$72,617.00

The cost and cost-effectiveness of frequent nocturnal hemodialysis compared with conventional intermittent hemodialysis: A decision analysis based on a randomized clinical trial

FY 2008-09

Summary
The number of patients with end-stage kidney disease (ESRD) continues to increase by 5-10% per year in Canada, with the majority of Canadian ESRD patients receiving treatment with hemodialysis, the most expensive type of dialysis. The annual risk of dying for dialysis patients averages 20%, and quality of life for these patients is similar to patients with advanced cancer. Recently, there has been renewed interest in frequent nocturnal hemodialysis (NHD), where patients perform dialysis at home five to six nights per week while they sleep. At present, very few patients in Canada receive nocturnal hemodialysis. Recently, our group published a randomized trial comparing the impact of frequent nocturnal hemodialysis and conventional intermittent dialysis on heart outcomes, and quality of life. While this study shows that frequent NHD reduces the size of the heart (suggesting that it may improve heart outcomes for these patients), and improves quality of life, at present, uncertainties remain with respect to the cost and therefore the cost-effectiveness of NHD. In this study, we plan to determine the cost-effectiveness of frequent nocturnal hemodialysis compared with conventional intermittent hemodialysis in eligible ESRD patients, and to compare the cost of nocturnal hemodialysis (both to the health care system and to the patients themselves) compared with conventional hemodialysis. This will be done by combining detailed clinical and costing data from our randomized trial using a technique called economic evaluation. In so doing, we will be able to determine whether nocturnal dialysis is a cost-effective therapy and whether it should be offered to more patients on dialysis. Given that we have information on the cost of nocturnal dialysis, not only to health care providers, but also to patients and their families, this analysis will be useful to patients who are considering this new treatment.
Program
Operating Grant: Priority Announcement (IHSPR)
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
179183
Name
Manns Braden J
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Health Policy & Systems Management Research
Projecttitle
The cost and cost-effectiveness of frequent nocturnal hemodialysis compared with conventional intermittent hemodialysis: A decision analysis based on a randomized clinical trial
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$72,617
Cihrequipment2
$0
Programname2
Operating Grant: Priority Announcement (IHSPR)
Keyworddelim
Cost; Economic Evaluation; Hemodialysis; Kidney Failure; Nocturnal Hemodialysis
Abstract
The number of patients with end-stage kidney disease (ESRD) continues to increase by 5-10% per year in Canada, with the majority of Canadian ESRD patients receiving treatment with hemodialysis, the most expensive type of dialysis. The annual risk of dying for dialysis patients averages 20%, and quality of life for these patients is similar to patients with advanced cancer. Recently, there has been renewed interest in frequent nocturnal hemodialysis (NHD), where patients perform dialysis at home five to six nights per week while they sleep. At present, very few patients in Canada receive nocturnal hemodialysis. Recently, our group published a randomized trial comparing the impact of frequent nocturnal hemodialysis and conventional intermittent dialysis on heart outcomes, and quality of life. While this study shows that frequent NHD reduces the size of the heart (suggesting that it may improve heart outcomes for these patients), and improves quality of life, at present, uncertainties remain with respect to the cost and therefore the cost-effectiveness of NHD. In this study, we plan to determine the cost-effectiveness of frequent nocturnal hemodialysis compared with conventional intermittent hemodialysis in eligible ESRD patients, and to compare the cost of nocturnal hemodialysis (both to the health care system and to the patients themselves) compared with conventional hemodialysis. This will be done by combining detailed clinical and costing data from our randomized trial using a technique called economic evaluation. In so doing, we will be able to determine whether nocturnal dialysis is a cost-effective therapy and whether it should be offered to more patients on dialysis. Given that we have information on the cost of nocturnal dialysis, not only to health care providers, but also to patients and their families, this analysis will be useful to patients who are considering this new treatment.
Competitiondate
200809
Approvedterm2
1 yr 0 mth
Pinamesdelim
Manns, Braden J; Klarenbach, Scott
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $72,617~ $0~
University of Calgary - $72,617 Grant (2008-09) | Canada Spends